Drug shortage: Midazolam Hydrochloride Injection (MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM)
FDA lists 27 presentations as Current. Availability: Unavailable (8), Limited Availability (3), Available (16). Reason: Demand increase for the drug; Other. Companies: Avet Pharmaceuticals, Inc., Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC, Gland Pharma Limited….
- Published by source
- 2020-04-02
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Avet Pharmaceuticals, Inc.
- Products
- Midazolam Hydrochloride Injection MIDAZOLAM HYDROCHLORIDE MIDAZOLAM
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Additional lots are scheduled to be manufactured. Product will be made available as it is released.
- Limited Supply Available. Next Delivery and Estimated Recovery: December 2026
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-04-02
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #847 | new | 2026-10-22 | 1cb08581ee43…c6a318 | 636d2007b835…531607 |
Chain head: #1094 edf3be25ec2e…478842